282 related articles for article (PubMed ID: 27239674)
21. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
22. The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.
De Matteis G; Zanotti R; Colarossi S; De Benedittis C; Garcia-Montero A; Bonifacio M; Sartori M; Aprili F; Caruso B; Paviati E; Carli G; Perbellini O; Zamò A; Bonadonna P; Pizzolo G; Guidi G; Martinelli G; Soverini S
Leuk Res; 2015 Mar; 39(3):273-8. PubMed ID: 25582384
[TBL] [Abstract][Full Text] [Related]
23. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
24. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management.
Pardanani A
Am J Hematol; 2023 Jul; 98(7):1097-1116. PubMed ID: 37309222
[TBL] [Abstract][Full Text] [Related]
25. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
Riffel P; Schwaab J; Lutz C; Naumann N; Metzgeroth G; Fabarius A; Schoenberg SO; Hofmann WK; Valent P; Reiter A; Jawhar M
J Cancer Res Clin Oncol; 2020 Apr; 146(4):945-951. PubMed ID: 31980928
[TBL] [Abstract][Full Text] [Related]
26. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
[TBL] [Abstract][Full Text] [Related]
27. Mastocytosis: classification, diagnosis, and clinical presentation.
Castells MC
Allergy Asthma Proc; 2004; 25(1):33-6. PubMed ID: 15055560
[TBL] [Abstract][Full Text] [Related]
28. Skin and bones: systemic mastocytosis and bone.
Wang M; Seibel MJ
Endocrinol Diabetes Metab Case Rep; 2023 May; 2023(2):. PubMed ID: 37166908
[TBL] [Abstract][Full Text] [Related]
29. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
[TBL] [Abstract][Full Text] [Related]
31. [Bone involvement in systemic mastocytosis: Report of two cases].
Florenzano P; Mezzano V; Le-Bert M; González G
Rev Med Chil; 2016 Mar; 144(3):401-5. PubMed ID: 27299829
[TBL] [Abstract][Full Text] [Related]
32. Systemic mastocytosis with
Conde-Fernandes I; Sampaio R; Moreno F; Palla-Garcia J; Teixeira MDA; Freitas I; Neves E; Jara-Acevedo M; Escribano L; Lima M
Allergy Asthma Clin Immunol; 2017; 13():21. PubMed ID: 28439288
[TBL] [Abstract][Full Text] [Related]
33. Highly sensitive assays are mandatory for the differential diagnosis of patients presenting with symptoms of mast cell activation: diagnostic work-up of 38 patients.
Van den Poel B; Kochuyt AM; Del Biondo E; Dewaele B; Lierman E; Tousseyn T; de Hertogh G; Vandenberghe P; Boeckx N
Acta Clin Belg; 2017 Apr; 72(2):123-129. PubMed ID: 28262030
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
35. Assessment of in vivo mast cell reactivity in patients with systemic mastocytosis.
Gülen T; Möller Westerberg C; Lyberg K; Ekoff M; Kolmert J; Bood J; Öhd J; James A; Dahlén SE; Nilsson G; Dahlén B
Clin Exp Allergy; 2017 Jul; 47(7):909-917. PubMed ID: 28258965
[TBL] [Abstract][Full Text] [Related]
36. [Mastocytosis, classification, biological diagnosis and therapy].
Arock M
Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
[TBL] [Abstract][Full Text] [Related]
37. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
Pullarkat ST; Wu W; Pullarkat V
Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
[TBL] [Abstract][Full Text] [Related]
38. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia.
Krokowski M; Sotlar K; Krauth MT; Födinger M; Valent P; Horny HP
Am J Clin Pathol; 2005 Oct; 124(4):560-8. PubMed ID: 16146815
[TBL] [Abstract][Full Text] [Related]
39. Bone lesions in systemic mastocytosis: Bone histomorphometry and histopathological mechanisms.
Bouvard B; Pascaretti-Grizon F; Legrand E; Lavigne C; Audran M; Chappard D
Morphologie; 2020 May; 104(345):97-108. PubMed ID: 32127247
[TBL] [Abstract][Full Text] [Related]
40. An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.
Teodosio C; García-Montero AC; Jara-Acevedo M; Alvarez-Twose I; Sánchez-Muñoz L; Almeida J; Morgado JM; Matito A; Escribano L; Orfao A
Leukemia; 2012 May; 26(5):951-8. PubMed ID: 22051531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]